Date: March 6, 2018
Location: Taipei, Taiwan
| Time | Opening Remark | ||
| 09:00-09:05 | Dr. Tzou-Yien Lin | Chair person, Board of Directors, NHRI, Taiwan | |
| I. Taiwan Regulation Section | |||
| Topic | Speaker | Moderator | |
| 09:05-09:30 | Development of Enterovirus71 (EV71) Vaccines in Taiwan | Dr. Min-Shi Lee NHRI, Taiwan |
Dr. Mei-Shang Ho Academia SINICA, Taiwan |
| 09:30-10:00 | Clinical Perspective on EV 71 Vaccines Regulation in Taiwan | Dr. Ya-Lei Wang CDE, Taiwan |
|
| 10:00-10:30 | CMC Perspective on EV 71 Vaccines Regulation in Taiwan | Dr. Yu-Ping Ho CDE, Taiwan |
|
| 10:45-11:15 | Lot Release System for Vaccines in Taiwan | Dr. Yi-Chen Yang FDA, MOHW, Taiwan |
|
| 11:15-11:40 | Current Status and Future Plans for Clinical Trial of EV 71 Vaccines (Enimmune) | Dr. Chin-Fen Yang Enimmune, Taiwan |
|
| 11:45-12:15 | Current Status and Future Plans for Clinical Trial of EV 71 Vaccines (Medigen) | Dr. Kathy Tai Medigen Vaccines, Taiwan |
|
| II. Vietnam Regulation Section | |||
| 13:30-14:00 | Review on IND of Human Vaccines in Vietnam | Dr. Nguyen Ngo Quang ASTT, MOH, Vietnam |
Prof. Oliver Yoa-Pu Hu Taipei Medical University, Taiwan |
| 14:00-14:30 | Regulati on on Surveillance of Adverse Event Following Immunization | Dr. Nguyen Minh Hang GDPM, MOH, Vietnam |
|
| 14:30-15:00 | Implementation of Vaccine Trials in Vietnam, Experiences from the Pasteur Institute Ho Chi Minh City | Dr. Nguyen Vu Thuong Paster Institute-HCMC, Vietnam |
|
| 15:15-15:45 | Experiences Sharingon Multi-national Clinical Trials of Pediatric Vaccines in Vietnam | Dr. Nguyen Trong Toan Paster Institute-HCMC, Vietnam |
Dr. Min-Shi Lee NHRI, Taiwan |
| 15:45-16:15 | Cost of Illness of HFMD in Vietnam | Dr. Le Nguyen Thanh Nhan Children’s Hospital 1, HCMC, Vietnam |
|
| 16:15-16:45 | Experiences sharing on clinical trials of pediatric vaccines in Vietnam | Dr. Do Tuan Dat VABIOTECH Vaccine, Vietnam |
|